Synopsis:
Bank of America (BOFA) bought significant stakes from Goldman Sachs in two block deals: ICICI Bank and Apollo Hospitals. BOFA acquired 1,41,886 ICICI Bank shares at Rs 1,332 each (about Rs 19 crore) and 92,363 Apollo Hospitals shares at Rs 7,474 each (about Rs 69 crore). These deals signal strong institutional interest in these sectors.
Investors should focus on block deals as they signal confidence from major institutional players acquiring significant stakes, which can stabilize stock prices and attract further interest. Such transactions reflect strategic portfolio realignment and long-term trust in the sector, influencing market sentiment and industry growth.
ICICI Bank
A major Indian bank started in 1955 to help businesses grow with loans. It now offers simple services like savings accounts, loans, and insurance to people and companies. With over 7,000 branches and 10,000 ATMs across India, plus spots in 17 countries, it serves millions safely and quickly.
ICICI Bank Limited’s stock, with a market capitalisation of Rs. 9,65,721 crores, rose to Rs. 1,354.90, hitting a high of up to 0.51 percent from its previous closing price of Rs. 1,348. Furthermore, the stock over the past year has given a return of 6.5 percent.
ICICI Bank saw a block deal at Rs 1,332 per share. BOFA Securities Europe SA purchased 1,41,886 shares from Goldman Sachs Bank Europese-ODI, who sold the exact quantity. The total value transacted was approximately Rs 18.89 crore.
The company’s earnings in Q2-2026 showed solid growth. Profit before tax, not counting treasury income, rose by 9.1% year-over-year to Rs. 16,100 crore. Core operating profit increased by 6.5% to Rs. 17,078 crore, and profit after tax grew 5.2% to Rs. 12,359 crore, highlighting steady gains in all key profit figures.
Deposits and loan growth were also strong during this period. Total deposits grew 9.1% year-over-year, with savings deposits up 8.5% and current account deposits up 12.6%. Domestic loans went up 10.6% year-over-year, with retail loans rising by 6.6% and business banking portfolios growing by 24.8%. These results show the company is expanding in both earnings and lending activities.
Apollo Hospitals Enterprise
Apollo Hospitals is India’s top private health group, founded in 1983 by Dr. Prathap C. Reddy in Chennai. It runs 71 hospitals with more than 10,000 beds, plus pharmacies, clinics, and online doctor services. Known for top care in heart, cancer, and bone treatments, it uses new tech to help over 150 million patients from 140 countries.
Apollo Hospitals Enterprise Limited’s stock, with a market capitalisation of Rs. 1,07,126 crores, fell to Rs. 7,442, hitting a low of up to 1.16 percent from its previous closing price of Rs. 7,529.50. Furthermore, the stock over the past year has given a return of 4.28 percent.
Apollo Hospitals witnessed a block deal executed at Rs 7,474 per share, with BOFA Securities Europe SA acquiring 92,363 shares from Goldman Sachs Bank Europese-ODI, matching the volume sold. The transaction was valued at around Rs 68.99 crore, indicating significant institutional confidence and showing the persistent demand for Apollo Hospitals stock among major market players.
The company reported revenue of Rs. 6,304 crore in Q2FY26, rising 12.8% year-on-year from Rs. 5,589 crore in Q2FY25 and up 7.9% quarter-on-quarter from Rs. 5,842 crore in Q1FY26. This steady growth reflects improving demand and operational efficiency, supported by a three-year sales CAGR of 14%.
Net profit stood at Rs. 494 crore in Q2FY26, increasing 24.7% YoY from Rs. 396 crore and 12% QoQ from Rs. 441 crore. The company’s strong profitability trend is reinforced by a 3-year profit CAGR of 18% and ROE CAGR of 15%, highlighting consistent earnings and efficient capital deployment.
Written By Fazal Ul Vahab C H
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
